Pharmacokinetic Study Comparing Two Salmeterol Fluticasone Propionate Device-metered Dry Powder Inhalers, Salmeterol/Fluticasone Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; a Randomised, Double blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Latest Information Update: 16 Jan 2014
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Orion
- 16 Jan 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 23 May 2013 New trial record